Foley Mark J 4
4 · Revance Therapeutics, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Foley Mark J
DirectorCEO
Transactions
- Award
Common Stock
2025-02-03+27,933→ 1,024,868 total
Holdings
- 110,913(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Represents the vesting of performance-based restricted stock units (PSUs) granted on January 31, 2023, which vest over a three-year period based on the achievement of revenue goals. On February 3, 2025, the Issuer's Compensation Committee certified a portion of the PSUs eligible to vest based on (i) the achievement of a revenue goal, measured beginning January 1, 2024 through December 31, 2024, and (ii) subject to the Reporting Person remaining in continuous service through the vesting date.
- [F2]These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.